Private Market View

Chronic Insights

Durham, United Kingdom · Founded 2018 · Privately Held (backing)

Last price · $/share
Implied valuation
Total raised
Last round

Key facts

  • Notable investors include Northstar Ventures.
  • Status: Privately Held (backing).
Free account
See the evidence behind this price
  • ·The complete investor list — 1 names
  • ·Watchlist + deal alerts for Chronic Insights
  • ·The full record, as it builds
Create free account
No card required

Funding rounds

No rounds on record

No funding rounds for Chronic Insights are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

About Chronic Insights

Developer of a pain tracking application designed to offer medications and body measurements. The company's application records symptoms and configures them as a bar chart or a line chart, as well as records blood and urine test results, mood, vitals and weather data, enabling patients to get insights about their health condition.

Sector
Consumer Products and Services (B2C)
HQ
Durham, United Kingdom
Founded
2018
Employees
1
Ownership
Privately Held (backing)
PA Mark — not yet priced

Chronic Insights doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in Chronic Insights shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on Chronic Insights in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.